Download the BioTrinity 2015 Profile Raising Opportunities Brochure here

BioTrinity 2015 - European Biopartnering and Investment Conference - May 11-13, 2015


Where Great MindsSmart Money and Key Dealmakers Meet

BioTrinity is the Leading European Biopartnering and Investment Conference. Building on a reputation established over eight years of organising what is now the largest biopartnering conference delivered by an industry organisation, BioTrinity 2015 brings together R&D companies, big pharma and medtech corporates with more biomedical investors than any other European partnering conference.

BioTrinity will return to central London in 2015 and it promises to be the biggest and best conference yet. BioTrinity 2015 will take place at the Novotel London West, located just 30 minutes travel time from Heathrow with plenty of hotel accommodation in the area.

In 2014 we hosted 2,462 one-to-one meetings over two days between 1,014 delegates from 32 countries, representing more than 624 companies, reinforcing BioTrinity's position as Europe's Leading Biopartnering and Investment Conference.

Meet the key licensing contacts from large corporates including AbbVie, Amgen, Astellas, AstraZeneca, Boehringer, Bristol-Myers Squibb, Chiesi, Eli Lilly, Genzyme, GE, GlaxoSmithKline, Johnson & Johnson, Life Technologies, Linde AG, MSD, Novartis, Novo Nordisk, Sanofi-Aventis, Sanofi-Pasteur, Shire, Pfizer, Roche, Takeda as well as mid-sized including Vertex, Ferrer, Actelion, MorphoSys, Nordic Pharma, Norgine, Qiagen, QuantuMDx, and other senior BD&L executives.

Meet over 100 delegates from active VC and Corporate Venture firms including MedImmune Ventures, SR One, Johnson & Johnson Development Corporation, AbbVie Inc, Mitsui & Co, MPH Ventures, Norgine Ventures, Novartis Venture Fund, MS Ventures, MRL Venture Fund, Takeda Ventures, Unilever Ventures, Boehringer Ingelheim Ventures, Inventages, as well as Lundbeckfond Ventures, Novo A/S, Syncona, Index, Sofinnova, EdRIP and many international VCs.

Thanks to EBD Group's partneringONE®, the industry gold-standard partnering system with entirely private partnering: 

partneringOne

You need to upgrade your Flash Player


The "Event of the Year" - BioTrinity 2014:

Huge partnering potential with global pharma / investors

 100 presentations by hand-picked R&D companies

 Innovative "Connect for Growth" zones that encouraged informal and formal collaborative interactions

Great networking opportunities with 1000 delegates

 First class venue at Novotel London West

Exciting Social Programme:

 The Big London Networking Party, BioTrinity Welcome Reception and Connect for Drinks

 Europe's Largest Investor-only Dinner

Check out the glowing testimonials we received for BioTrinity, or view the photos from the Gallery





BioTrinity 2014 highlights
1,014 delegates from 32 countries
624 companies
184 speakers
107 company showcase presentations
2,462 one-to-one meetings
130+ investor delegates from 12 countries
61 exhibitors
80 global pharma/corporate venture delegates
33 global pharma/medical technology corporates